HIV, acquired immunodeficiency syndrome, immune reconstitution inflammatory syndrome, antiretroviral therapy, highly active, movement disorders, Guillain- Barré syndromeVIH, síndrome de inmunodeficiencia humana, síndrome inflamatorio de reconstitución inmunológica, terapia HAART, coreoatetosis, polineuropatía desmielinizante inflamatoria aguda, síndrome de Guillain-Barré,

1. Shelburne SA 3rd, Hamill RJ. The immune reconstitution inflammatory
syndrome. AIDS Rev. 2003;5:67-79.
2. Venkataramana A, Pardo CA, McArthur JC, Kerr DA, Irani DN, Griffin JW, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology. 2006;67:383-8.
3. Tsang CS, Samaranayake LP. Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: A review. Oral Dis. 2010; 16(3):248-56.
4. French MA, Lenzo N, John M, Mallal SA, McKinnon EJ, James IR, et al.
Immune restoration disease after the treatment of immunodeficient HIVinfected patients with highly active antiretroviral therapy. HIV Med.
2000;1:107-15.
5. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-61.
6. Haddow LJ, Easterbrook PJ, Mosam A, Khanyile NG, Parboosing R, Moodley P. Defining immune reconstitution inflammatory syndrome: Evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis. 2009;49:1424-32.
7. Shelburne SA 3rd, Hamill RJ, Rodríguez-Barradas MC, Greenberg
SB, Atmar RL, Musher DW, et al. Immune reconstitution inflammatory
syndrome: Emergence of a unique syndrome during highly active
antiretroviral therapy. Medicine. 2002;81:213-27.
8. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18:1615-27.
9. Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251-61.
10. Trocello JM, Blanchet A, Bourdain F, Meyohas MC, Vidailhet M. Resolution of choreic movements associated with HIV encephalitis with anti-retroviral therapy. Rev Neurol (Paris). 2006; 162:89-91.
11. Passarin MG, Alessandrini F, Nicolini GG, Musso A, Gambina G, Moretto G. Reversible choreoathetosis as the early onset of HIV-encephalopathy. Neurol Sci. 2005;26:55-6.
12. Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W.
Movement disorders and AIDS: A review. Parkinsonism Relat Disord.
2004;10:323-34.
13. Cardoso F. HIV-related movement disorders: Epidemiology, pathogenesis and management. CNS Drugs. 2002;16:663-8.
14. Teo EC, Azwra A, Jones RL, Gazzard BG, Nelson M. Guillain-Barré
syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther. 2007;12:62-3.
15. Stahl D, Lacroix-Desmazes S, Misra N, Karmochkine M, Kaveri SV,
Costagliola D, et al. Alterations of selfreactive antibody repertoires in HIV
disease: An insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett. 2005;99:198-208.
16. Brannagan TH 3rd, Zhou Y. HIVassociated Guillain-Barré syndrome. J
Neurol Sci. 2003;208:39-42.
17. Bernal-Cano F. El virus de inmunodeficiencia humana VIH y el
sistema nervioso. Principios generales. Acta Neurol Colomb. 2008;24:124-41.
18. Berger JR. Steroids for PML-IRIS: A double-edged sword? Neurology.
2009;72:1454-5.

Vol. 52 Núm. 1 (2011)